Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial inner membrane (IMM) lipid pool, specifically the phospholipid cardiolipin, and its interaction with electron transport chain (ETC) complexes I–III form a critical functional unit for cellular energy production (Birk et al., 2013, British Journal of Pharmacology). Cardiolipin acts as a structural scaffold that organizes individual ETC complexes into supercomplexes, which facilitates efficient electron transfer and minimizes the leakage of electrons that leads to oxidative stress (Paradies et al., 2014, Advances in Bioscience and Biotechnology). In various pathological states, cardiolipin is susceptible to peroxidation or depletion, causing the dissociation of these supercomplexes and resulting in mitochondrial dysfunction and reduced ATP synthesis (Szeto, 2014, British Journal of Pharmacology). This target system is central to the etiology of primary mitochondrial diseases like Barth syndrome and mitochondrial myopathy, as well as secondary dysfunction in cardiovascular and neurodegenerative conditions (Chavez et al., 2020, Journal of the American Heart Association). Therapeutic agents such as elamipretide (SS-31) target this system by binding to cardiolipin, thereby stabilizing the IMM and restoring the optimal activity of complexes I and III (Allen et al., 2020, Neurotherapeutics). By preserving mitochondrial structural integrity, these interventions aim to improve bioenergetic capacity and reduce the production of damaging reactive oxygen species (Chatterjee et al., 2016, Journal of Biological Chemistry).
Stabilization of cardiolipin within the inner mitochondrial membrane to promote the structural integrity of cristae and optimize the assembly and efficiency of electron transport chain supercomplexes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial inner membrane lipid pool and electron transport chain complexes I–III (IMM lipid-ETC complex).